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1. Introduction  
Since the development of recombinant DNA technology (Cohen et al., 1973), it became 
possible to express heterologous genes in pro- or eukaryotic hosts, i.e. genes which they 
naturally not express. This development enabled the production of all kinds of products of 
which the high-added value recombinant proteins, became increasingly important and as 
such boosted biopharmaceutical and industrial enzyme applications. Up to now, the FDA 
(Food and Drug Administration) and EMEA (European Medicines Agency) have licensed 
the application of more than 150 recombinant proteins to be used as a pharmaceutical 
(Ferrer-Miralles et al., 2009). Global sales of biopharmaceuticals are estimated to account for 
US$70–80 Billion today (Walsh, 2010). Industrial enzymes (e.g. proteases, amylases, lipases, 
cellulases, pullulanases, pectinases) are used in various industrial segments and the 
industrial enzyme market is still expanding, estimated to reach US$ 3.74 Billion by the year 
2015 (Global Industry Analysts, 2011). To date, the majority of this industrial enzyme 
market value is generated by recombinant processes (Hodgson, 1994; Demain & Vaishnav, 
2009). 
It is clear that recombinant protein production has evolved to one of the most important 
branches in modern biotechnology, representing a billion-dollar business, both in the 
production of biopharmaceuticals and industrial enzymes.  
A pivotal choice in the design of a recombinant protein bioprocess is the selection of a 
suitable host strain. This selection is influenced by different factors: (i) ease of cultivation 
and growth characteristics, (ii) ease of genetic manipulation and availability of molecular 
tools, (iii) ability of post-translational modifications (e.g. glycosylation patterns, disulfide 
bond formation), (iv) downstream processing, and (v) regulatory aspects (generally 
regarded as safe, SAFE (Lotti et al., 2004; Sahdev et al., 2008; Durocher & Butler, 2009). 
These aspects will determine whether the designed recombinant protein bioprocess will end 
up in an economical viable bioprocess which can compete with the present process.  
In contrast to biopharmaceuticals, industrial enzyme bioprocesses are only economical 
viable as a low production cost is assured. This implies that higher yields, titres and 
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production rates are necessary which can only be obtained by fast growing organisms. This 
is reflected by the distribution of the most commonly used organisms in these two 
industries. Whereas slow growing organisms as plants and animals are used as host in half 
of the biopharmaceutical processes, they count only for 12% of the processes in the 
industrial enzyme market (Demain & Vaishnav, 2009; Ferrer-Miralles et al., 2009). Bacteria 
on the other hand, have a market share of 30% in both industries. However, yeasts and 
molds, which grow much faster in comparison with higher eukaryotes, are used in 58 % of 
the cases in the industrial enzyme market and only in 18% of the cases in the in the 
biopharmaceutical market. 
Several bacteria have been explored as host for recombinant protein production. Recently, 
much interest is raised in the use of Bacillus strains as host for recombinant protein 
production because of their advantageous features as gram-positive (Terpe, 2006). However, 
till today Escherichia coli remains a very popular and predominantly used bacterium for 
recombinant protein production. This is primarily because this well-characterised organism 
can easily and rapidly grow on cheap substrates and can be simply modified through a 
broad variety of molecular tools. But even more, the further exploration of other potential 
microbial hosts are often restricted due to limited information about genetics and 
metabolism and/or the availability of molecular tools. 
2. Escherichia coli for recombinant protein production 
Besides the advantage of many available molecular tools, the easily cultivable and 
genetically and metabolically well-known Escherichia coli can be grown to high biomass 
concentrations in high cell density cultures allowing the production of high amounts of 
heterologous protein (Makrides, 1996). Nonetheless, E. coli suffers from some major 
drawbacks as well.  
i. The production of heterologous proteins to high titres concurs mostly with the initiation 
of a stress response and/or metabolic burden, both associated with the use of multi-
copy plasmids, resulting in misfolding and degradation of the heterologous protein and 
formation of inclusion bodies (Noack et al., 1981; Parsell & Sauer, 1989; Bentley et al., 
1990; Gill et al., 2000; Hoffmann & Rinas, 2004; Ventura & Villaverde, 2006). 
ii. As prokaryotic, Escherichia coli lacks the ability to perform enhanced post-translational 
modifications making the production of more complex eukaryotic proteins in E. coli 
challenging. This inability to form disulfide bonds or to execute glycosylation results in 
the production of instable and non-functional proteins. 
iii. Secretory production of recombinant proteins into the culture medium includes several 
advantages, especially in cases of toxic recombinant proteins. However, compared to 
other hosts, E. coli does not naturally secrete proteins in high amounts. Nonetheless, E. 
coli possesses different secretions systems for the transport of proteins from the 
cytoplasmic to the perisplasmic or extracellular environment (Tseng et al., 2009). 
Crucial hereby is the signal peptide which is linked to the protein allowing recognition 
and transport by the secretion system.  
iv. The main difficulty when using E. coli as host is the production of acetate as by-product 
during fermentations as a result of overflow metabolism occurring when cells grow 
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rapidly and cannot metabolise the delivered carbon source fast enough (Andersen & 
von Meyenburg, 1980; Holms, 1986). It is generally observed that even low 
concentrations of acetate can hamper growth and obstruct the production of 
recombinant proteins (Jensen & Carlsen, 1990; Nakano et al., 1997).  
Many efforts have been made to overcome these hurdles and hence to increase recombinant 
protein production in E. coli or to express more complex proteins in this host. These 
engineering attempts are summarized in Fig. 1. 
 
Fig. 1. Overview of different engineering approaches to increase recombinant protein 
production in Escherichia coli 
The primarily used approach to produce recombinant proteins is to clone the gene of 
interest on a multi-copy plasmid under the control of a strong promoter in order to achieve 
high transcription rates and hence high recombinant protein concentrations. However, 
problems such as metabolic burden, segregational instability, misfolding and proteolytic 
breakdown or aggregation in inclusion bodies, and difficulties in controlling gene 
expression are usually associated with multi-copy plasmids and the use of strong promoters 
(Noack et al., 1981; Parsell & Sauer, 1989; Bentley et al., 1990; Dong et al., 1995; Kurland & 
Dong, 1996; Gill et al., 2000; Hoffmann & Rinas, 2004; Ventura & Villaverde, 2006). Most 
engineering strategies to tackle these problems focus on prevention of misfolding, 
neutralisation of increased protease activity or stress response (Chou, 2007). An elaborated 
review of these efforts is given in (Waegeman & Soetaert, 2011). 
Two post-translational modifications which are pivotal for the stability and activity of 
many more complex eukaryotic proteins are disulfide bonds and glycosylation. The 
former is being facilitated in E. coli by secreting the recombinant protein into the more 
oxidizing perisplasmic space using the Sec or Tat secretion system, by altering the redox 
state of the cytoplasm through modifications in the thioredoxin reductase gene (trxB) and 
gluthatione reductase genes (gor) or by cytoplasmic overexpression of periplasmic 
disulfide oxidoreductases (such as DsbC) which enhance the rate of disulfide 
isomerisation. An excellent review of these engineering strategies can be found in (de 
Marco, 2009). 
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Besides the proper formation of disulfide bonds, E. coli also lacks the ability of glycosylation. 
In order to make E. coli produce N-linked glycoproteins the gene cluster pgl, responsible for 
glycosylation in Campylobacter jejuni (Szymanski et al., 1999; Abu-Qarn et al., 2008) was 
successfully transferred (Wacker et al., 2002). Moreover, combination of the pgl system with 
a simple, genetically encoded glycosylation tag, expands the glycosylation possibilities of E. 
coli (Fisher et al., 2011). 
The secretory production of recombinant proteins into the fermentation broth includes 
several advantages compared to cytoplasmic production. Although E. coli has different 
secretion systems for transport of proteins, secretion of recombinant proteins is rather 
complex. Many research efforts focus on the utilisation of these existing transport routes for 
the secretion of heterlogous proteins (Choi & Lee, 2004; Jong et al., 2010) including selection 
and modification of the signal peptide, coexpression of proteins that assist in translocation 
and folding, improvement of periplasmic release when transport occurs in two steps or 
protection of the target protein from degradation and contamination (Abdallah et al., 2007). 
3. An alternative approach to reduce acetate production and improve 
recombinant protein production in Escherichia coli 
Throughout the years, various Escherichia coli strains with different genotypes have been 
examined for their potential to produce recombinant proteins in high titres. A 
comprehensive overview of all E. coli strains used in recombinant protein production 
processes and their characteristics is given in (Waegeman & Soetaert, 2011). Although E. coli 
B and E. coli K12 strains are equally used as host for recombinant protein production (47% 
and 53%, respectively), E. coli BL21 is by far the most commonly used strain (35%) in 
academia. In industry, this number is probably even much higher. 
Escherichia coli BL21 displays higher biomass yields compared to E. coli K12 resulting in 
substantially lower acetate amounts which in return has a positive effect on the recombinant 
protein production (El-Mansi & Holms, 1989; Shiloach et al., 1996). The second reason of the 
extensive use of E. coli BL21 as microbial host for recombinant protein production is that this 
strain is deficient in the proteases Lon and OmpT, which decreases the breakdown of 
recombinant protein and result in higher yields (Gottesman, 1989; Gottesman, 1996). 
However, until recently the genome sequence of E. coli BL21 was not available making 
genetically modifications not always straightforward and therefore challenging. 
Consequently, still a lot of attention and effort is going towards E. coli K12-derived strains as 
most favourable E. coli strain for recombinant protein production (Ko et al., 2010; Ryu et al., 
2010; Striedner et al., 2010). 
Many different strategies have been applied to increase recombinant protein formation and 
decrease acetate formation in E. coli K12 strains including optimisation of the bioprocess 
conditions as metabolic engineering of the production host (De Mey et al., 2007b). These 
approaches comprise attempts which can be categorised in 3 classes: (i) deletion of acetate 
pathway genes, (ii) avoiding overflow metabolism by limiting the glucose uptake system 
through alteration of the carbon source, applying elaborate feeding strategies, or 
engineering the glucose uptake system, and (iii) avoiding overflow metabolism by 
redirecting central metabolic fluxes and preserving sufficient precursors of the amino acids, 
the building blocks of proteins (Fig. 2). 
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Fig. 2. Strategies to reduce acetate formation in Escherichia coli (adapted from Waegeman & 
Soetaert, 2011): (i) blocking the acetate pathway by knocking out genes that encode for acetate 
pathway enzymes, (ii) reducing the glucose uptake rate, and (iii) redirecting central metabolic 
fluxes. PPP, pentose phosphate pathway; aceA, isocitrate lyase; aceB, malate synthase; ackA, 
acetate kinase; acn, aconitase; acs, acetyl-CoA synthase; adhCEP, ethanol dehydrogenase; adhE, 
aldehyde dehydrogenase; fumABCD, fumarase; galP, galactose permease; glk, glucokinase; icd, 
isocitrate dehydrogenase; ilvBG2HIMN, acetolacetate decarboxylase; ldhA, lactate 
dehydrogenase; maeAB, malic enzyme; mdh, malate dehydrogenase; pck, phosphoenolpyruvate 
carboxykinase; pdh, pyruvate dehydrogenase; pflB, tdcE, pyruvate formate lyase; poxB, 
pyruvate oxidase; ppc, phosphoenolpyruvate carboxylase; pps, phosphoenolpyruvate synthase; 
pta, acetylphosphotransferase; pyk, pyruvate kinase; sdhABCD, succinate dehydrogenase; 
sucAB, a-ketoglutarate dehydrogenase; sucCD, succinate thiokinase. 
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The first, rational effort to decrease acetate production is to block the acetate pathway by 
knocking out genes that encode for acetate pathway enzymes, e.g. ackA (acetate kinase), pta 
(phosphate acetyltransferase) and poxB (pyruvate oxidase) (Diaz-Ricci et al., 1991; Yang et 
al., 1999; Contiero et al., 2000; Dittrich et al., 2005; De Mey et al., 2007a). These attempts 
resulted in a considerably decrease of acetate production but in return pyruvate, lactate or 
formate formation, which are also undesired by-products, increased to a large extent. 
A second widely followed approach to minimise acetate formation during high cell density 
fermentations is to limit rapid uptake of glucose causing overflow metabolism. Overflow 
metabolism occurs when high glycolytic fluxes, due to rapid glucose uptake, are not further 
processed in the TCA cycle developing a bottleneck at the pyruvate node and consequently 
pyruvate is converted to acetate.  
Strategies based on optimising the bioprocess conditions to reduce the glucose uptake rate 
comprise applying specific glucose feeding patterns, the application of alternative substrates, 
the addition of supplements to the medium, the control of a range of fermentation parameters 
and the application of systems to remove acetate from the fermentation broth (Farmer & Liao, 
1997; Nakano et al., 1997; Akesson et al., 1999; Akesson et al., 2001b; Akesson et al., 2001a; 
Fuchs et al., 2002  ; Chen et al., 2005; Eiteman & Altman, 2006). Although all these attempts 
were in many cases successful to reduce acetate production, they imply a severe lower growth 
rate and they do not utilise the full potential of the microbial host.  
Engineering of the glucose uptake system is being successfully applied as well to overcome 
overflow metabolism. By deleting one of the phosphotransferase system genes, e.g. ptsG, 
ptsH or ptsI, the uptake through the major glucose transporter is several impeded, resulting 
in a reduced glycolytic flux and reduced acetate pathway (Chou et al., 1994; Siguenza et al., 
1999; De Anda et al., 2006; Wong et al., 2008). To restore the strong reduction in growth rate 
as consequence of hampering the main glucose transporter De Anda et al. (2006) 
overexpressed the alternative glucose transporter gene galP (coding for a galactose 
permease) and exploited the native glucose kinase (Glk) transporter. The resulting strain E. 
coli W3110 ∆ptsH galP+ displayed a very low acetate yield and a significantly increased 
recombinant protein yield compared to the E. coli W3110 wild-type, without reduction in 
growth rate. Wong et al (2008) restored glucose transport by co-expressing the gene glf, 
encoding for a passive glucose transporter of Zymomonas mobilis. However, this only 
resulted in a decreased acetate formation in M9 minimal media, not in LB media. 
A third approach to overcome overflow metabolism is to redirect the fluxes around the 
bottleneck, the phosphoenolpyruvate-pyruvate-oxaloacetate node, instead of restricting the 
glucose uptake. Farmer & Liao (1997) increased anaplerotic and glycolate fluxes by 
overexpressing phosphenolpyruvate carboxylase (encoded by ppc) and by deleting the FadR 
regulator. This notable strategy resulted in a more than 75% decrease in acetate yield 
compared to its wild type. Alternatively, another important success was achieved by the 
overexpression of a heterologous anaplerotic pyruvate carboxylase from Rhizobium etli 
resulting in a 57% reduction in acetate formation and a 68% increase in recombinant protein 
production (March et al., 2002). Similarly, De Mey et al. (2010) achieved an increase in 
recombinant protein production by deleting the genes coding for acetate pathway enzymes 
combined with the overexpression of ppc. 
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An alternative approach to enhance recombinant protein production is mimicking the E. coli 
BL21 phenotype in E. coli K12 by interfering on the regulatory level of gene expression 
instead of targeting genes directly involved in the conversion of metabolites in the acetate 
pathway our around the phosphoenolpyruvate-pyruvate-oxaloacetate node. 13C metabolic 
flux analysis showed that the low acetate production in E. coli BL21(DE3) is caused by 
activation of the glyoxylate pathway (Noronha et al., 2000), a pathway which is normally 
not activated under glucose excess in E. coli K12 strains. Furthermore, acetate assimilation 
pathways are more active in E. coli BL21 compared to in E. coli K12 (Phue et al., 2005). 
3.1 Influence of transcriptional regulators ArcA and IclR on Escherichia coli 
phenotypes 
Regulation of gene expression is very complex and transcriptional regulators can be 
subdivided in global and local regulators depending on the number of operons they control. 
Global regulators control a vast number of genes, which must be physically separated on the 
genome and belong to different metabolic pathways (Gottesman, 1984). According to 
EcoCyc (Keseler et al., 2011) E. coli K12 MG1655 contains 40 master regulators and sigma 
factors. Nonetheless, only seven global regulators control the expression of 51% of all genes: 
ArcA, Crp, Fis, Fnr, Ihf, Lrp and NarL. In contrast to global regulators, local regulators 
control only a few genes, e.g. 20% of all transcriptional regulators control the expression of 
only one or two genes (Martinez-Antonio & Collado-Vides, 2003). 
The global regulator ArcA (anaerobic redox control) was first discovered in 1988 by Iuchi 
and Lin and the regulator seemed to have an inhibitory effect on expression of aerobic TCA 
cycles genes under anaerobic conditions (Iuchi & Lin, 1988). Later on, it was unravelled that 
ArcA is a component of the dual-component regulator ArcAB, in which ArcA is the 
regulatory protein and ArcB acts as sensory protein (Iuchi et al., 1990).  
Acording to EcoCyc (Keseler et al., 2011) ArcA is involved in the regulation of 168 genes and 
itself is regulated by 2 regulators (FnrR, RpoD). Statistical analysis of gene expression data 
(Salmon et al., 2005) showed that ArcA regulates the expression of a wide variety of genes 
involved in the biosynthesis of small macromolecules, transport, carbon and energy 
metabolism, cell structure, etc. The regulatory activity of ArcA is dependent on the oxygen 
concentration in the environment. The most profound effects of ArcA are noticed under 
microaerobic conditions (Alexeeva et al., 2003) but recently it was reported that also under 
aerobic conditions ArcA has an effect on central metabolic fluxes (Perrenoud & Sauer, 2005). 
Similarly to the global transcriptional regulator ArcA, the local transcriptional regulator 
isocitrate lyase regulator IclR has a reductive effect on the flux through the TCA cycle 
(Rittinger et al., 1996). IclR represses the expression of the aceBAK operon, which codes for the 
glyoxylate pathway enzymes isocitrate lyase (encoded by aceA), malate synthase (encoded by 
aceB), and isocitrate dehydrogenase kinase/phosphatise (encoded by aceK) (Yamamoto & 
Ishihama, 2003). The last enzyme phosphorylates the TCA cycle enzyme isocitrate 
dehydrogenase (Icd) controlling the switch between the flux through the TCA cycle and the 
glyoxylate pathway. It is reported that when IclR levels are low or when IclR is inactivated, i.e. 
for cells growing on acetate (Cortay et al., 1991; Cozzone, 1998; El-Mansi et al., 2006), or in slow 
growing glucose utilising cultures (Fischer & Sauer, 2003; Maharjan et al., 2005), repression on 
glyoxylate genes is released and the glyoxylate pathway is activated.  
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As both transcriptional regulators, ArcA and IclR, are involved in controlling the flux 
through the TCA cycle and glyoxylate pathway, they are interesting targets for metabolic 
engineering for mimicking the E. coli BL21 phenotype in E. coli K12.  
To investigate their effect, single knockouts as a knockout combination were made in E. coli 
MG1655 (K12-strain). The different mutants and wild type were cultivated in a 2L stirred 
tank bioreactor under glucose abundant (batch cultivation) conditions in order to precisely 
determine extracellular fluxes and growth rates and consequently to evaluate the 
physiological and metabolic consequences of arcA and iclR deletions on E. coli MG1655. In 
order to evaluate if these effects are corresponding with the characteristics of E. coli BL21, 
this E. coli strain was also tested. The growth rates and the average carbon and redox 
balances of the different strains are shown in Table 1. 
 
E. coli strain µmax (h-1) Carbon (%) Redox (%) 
MG1655 0.66 ± 0.02 97 101 
MG1655 ∆arcA 0.60 ± 0.01 96 94 
MG1655 ∆iclR 0.61 ± 0.02 95 95 
MG1655 ∆arcA ∆iclR 0.44 ± 0.03 99 101 
BL21(DE3) 0.59 ± 0.02 93 99 
Table 1. Average maximum growth rate, carbon balance and redox balance for batch 
cultures of the investigated strains 
The arcA and iclR single knockouts strains have a slightly lower maximum growth rate. In 
contrary the combined arcA-iclR double knockout strain in E. coli MG1655 exhibits a 
substantial reduction of 38% in µmax. Fig. 3 shows the effect of these mutations on various 
product yields under abundant glucose conditions. The corresponding average redox and 
carbon balances close very well (Table 1). 
Product yields in c-mole/c-mole glucose for E. coli MG1655, MG1655 ∆arcA, MG1655 ∆iclR, 
MG1655 ∆arcA ∆iclR and BL21 under glucose abundant conditions. Oxygen yield is shown 
as a positive number for a clear representation, but O2 is actually consumed during 
experiments. The values represented in the graph are the average of at least two separate 
experiments and the errors are standard deviations calculated on the yields. 
Both the arcA and iclR knockout strains show an increased biomass yield in E. coli MG1655. 
When combining these deletions in E. coli MG1655 the yield is further increased to 0.063 ± 
0.01 c-mole/c-mole glucose, which approximates the theoretical biomass yield of 0.65 c-
mole/c-mole glucose (assuming a P/O-ratio of 1.4) (Varma et al., 1993a; Varma et al., 1993b) 
and slightly higher compared to the E. coli BL21(DE3) wild-type. The higher biomass yield 
in E. coli  MG1655 ∆arcA ∆iclR is accompanied by a 70% and 16% reduction in acetate and 
CO2 yields, respectively. This reduction in CO2 yield could indicate that the glyoxylate 
pathway is more active in the double knock-out mutant as is observed in E. coli BL21 
(Noronha et al., 2000).  
The deletion of local transcriptional regulator iclR reduces the acetate formation with 50% in 
E. coli MG1655. When the global transcriptional regulator arcA is additionally deleted, the 
acetate yield is even further decreased to a comparable value of E. coli BL21(DE3). 
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Fig. 3. Product yields of the different E. coli strains in batch cultures.  
13C-metabolic flux analysis confirmed our hypothesis that the deletion of both arcA and iclR 
in E. coli MG1655 alters central metabolism fluxes profoundly (Fig. 4). A higher flux at the 
entrance of the TCA cycle was observed due to arcA deletion resulting in a reduced 
production of acetate and less carbon loss. Due to the iclR deletion, the glyoxylate pathway 
is activated resulting in a redirection of 30% of the isocitrate molecules directly to succinate 
and malate without CO2 production.  
Moreover, similar central metabolic fluxes were observed in the combined arcA-iclR double 
knockout in E. coli MG1655 as in E. coli BL21(DE3). These results suggest that the expression 
levels of arcA and iclR are low in E. coli BL21. We could confirm that deletion of both arcA 
and iclR in E. coli BL21 had no severe implications on the phenotype (Waegeman et al., 
2011c). Only a slight decrease in growth rate was observed. Thus, this proves that ArcA and 
IclR are poorly active in E. coli BL21 whereas in E. coli K12 both regulators play an important 
role. This can be explained by mutations in the promoter region of iclR and a less efficient 
codon usage of arcA in E. coli BL21 (Waegeman et al., 2011a). 
Thus, by deletion of a local and global transcriptional regulator, ArcA and IclR respectively, 
we could mimic the physiological and metabolic properties of E. coli BL21 in an E. coli K12 
strain. Furthermore, only a small part of the tremendously elevated biomass yield was 
attributed to increased glycogen content (Waegeman et al., 2011a) making this strain an 
attractive candidate for recombinant protein production. 
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Fig. 4. Metabolic Flux distribution in E. coli MG1655, its derivate single knockout strains 
∆arcA and ∆iclR, and the double knockout strain ∆arcA ∆iclR, and E. coli BL21 cultivated in 
glucose abundant conditions. More specific details about the metabolic flux calculations can 
be found in (Waegeman et al., 2011a) 
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3.2 Escherichia coli MG1655 ∆arcA ∆iclR as potential candidate for recombinant 
protein production 
Our previous research has shown that similar metabolic and physiological characteristics as 
E. coli BL21 can be achieved in E. coli K12 by combined deletion of the global transcriptional 
regulator ArcA and the local transcriptional regulator IclR. 
To investigate whether these metabolic alterations in E. coli MG1655 also beneficially 
influence recombinant protein production, we compared the recombinant protein 
production of the metabolically engineered strain to E. coli BL21(DE3) using GFP (Green 
Fluorescent Protein)  as a biomarker (Fig. 5). 
Batch cultures were performed in 2L stirred tank bioreactors. Yields are calculated by 
dividing GFP and biomass concentrations during the cultivation phase when biomass 
concentrations are higher than 2 gL-1. The values represented in the graph are the average of 
at least two separate experiments and the errors are the standard deviations calculated on 
the yields. 
 
Fig. 5. Overall GFP yields of the different strains in batch cultures. 
To our regret, the combined arcA-iclR double knockout mutant did not perform as we 
anticipated. Although the increased biomass yield and decreased acetate yield in the double 
knockout beneficially influence recombinant protein production as a higher GFP yield was 
observed to its wild type E. coli MG1655 (30% increase in the double knockout strain), still a 
www.intechopen.com
 Advances in Applied Biotechnology 
 
138 
striking difference of more than 40% was detected compared to E. coli Bl21. Additionally, we 
observed that at higher cell densities (>2gL-1 CDW) the GFP concentrations decreases again 
suggesting proteases activity (Waegeman et al., 2011b).  
Proteases play an important role in the degradation of foreign proteins (Gottesman & 
Maurizi, 1992) and it is generally believed that recombinant proteins are better produced in 
E. coli BL21 and his derivates because these strains lack the cytoplasmic ATP-dependent 
protease Lon (Gottesman, 1989) and the periplasmic OmpT (Gottesman, 1996).  
Although also other proteases are known for the degradation of proteins, but in a lesser 
extent towards recombinant proteins (Jürgen et al., 2010) and since E. coli BL21 lacks the 
proteases Lon and OmpT, these proteases were also deleted in the E. coli MG1655 ∆arcA 
∆iclR strain. 
The additional deletion of the proteases Lon and OmpT, resulting in the quadruple 
knockout strain E. coli MG1655 ∆arcA ∆iclR ∆lon ∆ompT, could impede the breakdown of 
GFP at higher cell densities. The GFP yield obtained at the end of the glucose growth phase 
in bioreactor experiments approximates the GFP yield of E. coli BL21 (DE3). 
4. Conclusion 
To date, recombinant protein production has evolved to one of the most important branches 
in modern biotechnology, representing a billion-dollar business, both in the production of 
biopharmaceuticals and industrial enzymes. Although many organisms have been used as 
host, Escherichia coli is predominantly utilised as microbial host, representing 30% of the 
bioprocesses in both industries. 
Although, E. coli strains are popular because they are fast growers, metabolically and 
genetically well characterised, and many molecular tools are available, these strains display 
several drawbacks. Besides problems related to stress response, post-transcriptional 
modification and secretion of recombinant proteins, a major drawback is the formation of 
acetate in aerobic cultures which retards growth and impedes protein production. 
Logically, many endeavours have been reported to decrease acetate formation and increase 
recombinant protein production in this host. However, among the different E. coli strains, E. 
coli BL21 and his derivates show a significant low acetate formation compared to E. coli K12 
strains, making BL21 a standard host in industrial recombinant protein production 
bioprocesses. Though, E. coli BL21 is not the optimal host due to plasmid instability and, 
until recently, unknown genome sequence making genetic modifications challenging. 
Traditionally, acetate formation in E. coli K12 strains is tackled by blocking the acetate 
pathways or avoiding overflow metabolism through limiting the glucose uptake rate or 
redirecting the fluxes around the bottleneck, the phosphoenolpyruvate-pyruvate-
oxaloacetate node. Alternatively, we propose to copy similar physiological and metabolic 
properties of E. coli BL21 in E. coli K12. This was achieved by combined deletion of the 
global transcriptional regulator ArcA and the local regulator IclR. Albeit this metabolically 
engineered E. coli K12 derivate displayed higher biomass yield and lower acetate yield 
resulting in a substantially increase in recombinant protein yield, the protein yield was still 
considerably lower than the yield observed in E. coli BL21. This difference in recombinant 
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protein production is caused by proteolytic activity in E. coli K12, which does not occur in E. 
coli BL21 due to absence of the proteases Lon and OmpT. Additional deletion of these 
proteases in our combined arcA-iclR double knockout strain, hampered this proteolytic 
activity yielding recombinant protein levels similar to E. coli BL21. 
In conclusion, by deleting only four genes, i.e. arcA, iclR, lon, and ompT it was possible to 
mimic the phenotype of E. coli BL21 in E. coli K12. The metabolically engineered quadruple 
knockout strain exhibited not only a tremendous increase in biomass yield and severe 
decrease in acetate yield, the recombinant protein production increased by a factor 2, 
resulting in a strain that can compete with E. coli BL21 for the industrial production of 
recombinant proteins. These results are incentive to further optimization of E. coli as 
microbial host making E. coli an often-chosen host in industrial bioprocesses. 
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